2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update

Treatment choices for the “severe acute respiratory syndrome‐related coronavirus‐2 (SARS‐CoV‐2)” are inadequate, having no clarity on efficacy and safety profiles. Currently, no established intervention has lowered the mortality rate in the “coronavirus disease 2019 (COVID‐19)” patients. Recently, 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Zoufang, Chavda, Vivek P., Vora, Lalitkumar K., Gajjar, Normi, Apostolopoulos, Vasso, Shah, Nirav, Chen, Zhe-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041304/
https://www.ncbi.nlm.nih.gov/pubmed/35496298
http://dx.doi.org/10.3389/fphar.2022.899633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041304/
https://www.ncbi.nlm.nih.gov/pubmed/35496298
http://dx.doi.org/10.3389/fphar.2022.899633

Ejemplares similares